Clinical Trials Browser

Dimethyl Fumarate × Lymphoid × Clear all

NCT02546440 2023-03-31

DMF-CTCL

Phase 2 Completed

DermatologicLymphoid

Lymphoma, T-Cell, Cutaneous

NCT02784834 2019-09-19

Dimethylfumarate (DMF) in Relapsed/Refractory CLL/SLL

Phase 1 Terminated

2 enrolled 5 charts

LymphoidOther hematologic neoplasm

Neoplasms, Recurrence, Leukemia, Lymphocytic, Chronic, B-Cell